Ensituximab: Phase I/IIa data

Preliminary data from 17 evaluable patients with advanced pancreatic and colorectal cancer who progressed on standard therapy in the Phase IIa

Read the full 212 word article

How to gain access

Continue reading with a
two-week free trial.